567 related articles for article (PubMed ID: 24418732)
1. Hemolysis: a harbinger of adverse outcome after left ventricular assist device implant.
Cowger JA; Romano MA; Shah P; Shah N; Mehta V; Haft JW; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):35-43. PubMed ID: 24418732
[TBL] [Abstract][Full Text] [Related]
2. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device.
Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA
J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730
[TBL] [Abstract][Full Text] [Related]
3. Hemolysis in left ventricular assist device: a retrospective analysis of outcomes.
Ravichandran AK; Parker J; Novak E; Joseph SM; Schilling JD; Ewald GA; Silvestry S
J Heart Lung Transplant; 2014 Jan; 33(1):44-50. PubMed ID: 24418733
[TBL] [Abstract][Full Text] [Related]
4. A multicenter analysis of clinical hemolysis in patients supported with durable, long-term left ventricular assist device therapy.
Katz JN; Jensen BC; Chang PP; Myers SL; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2015 May; 34(5):701-9. PubMed ID: 25582036
[TBL] [Abstract][Full Text] [Related]
5. Device thrombosis in HeartMate II continuous-flow left ventricular assist devices: a multifactorial phenomenon.
Uriel N; Han J; Morrison KA; Nahumi N; Yuzefpolskaya M; Garan AR; Duong J; Colombo PC; Takayama H; Thomas S; Naka Y; Jorde UP
J Heart Lung Transplant; 2014 Jan; 33(1):51-9. PubMed ID: 24290832
[TBL] [Abstract][Full Text] [Related]
6. Discriminatory performance of positive urine hemoglobin for detection of significant hemolysis in patients with continuous-flow left ventricular assist devices.
Gavalas MV; Breskin A; Yuzefpolskaya M; Eisenberger A; Castagna F; Demmer RT; Flannery M; Garan AR; Takeda K; Takayama H; Naka Y; Topkara VK; Colombo PC
J Heart Lung Transplant; 2017 Jan; 36(1):59-63. PubMed ID: 27773451
[TBL] [Abstract][Full Text] [Related]
7. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
[TBL] [Abstract][Full Text] [Related]
8. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
[TBL] [Abstract][Full Text] [Related]
9. An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial.
Najjar SS; Slaughter MS; Pagani FD; Starling RC; McGee EC; Eckman P; Tatooles AJ; Moazami N; Kormos RL; Hathaway DR; Najarian KB; Bhat G; Aaronson KD; Boyce SW;
J Heart Lung Transplant; 2014 Jan; 33(1):23-34. PubMed ID: 24418731
[TBL] [Abstract][Full Text] [Related]
10. Are elevated serum haemolysis markers a harbinger of adverse events in HeartMate II patients?
Zayat R; Shoaib M; Khattab MA; Ahmad U; Goetzenich A; Stoppe C; Foldenauer AC; Moza A; Schnoering H; Autschbach R; Tewarie L
Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):5-12. PubMed ID: 29444250
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis of hemolysis and device thrombosis with lactate dehydrogenase during left ventricular assist device support.
Shah P; Mehta VM; Cowger JA; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):102-4. PubMed ID: 23968811
[No Abstract] [Full Text] [Related]
12. Survival after biventricular assist device implantation: an analysis of the Interagency Registry for Mechanically Assisted Circulatory Support database.
Cleveland JC; Naftel DC; Reece TB; Murray M; Antaki J; Pagani FD; Kirklin JK
J Heart Lung Transplant; 2011 Aug; 30(8):862-9. PubMed ID: 21621423
[TBL] [Abstract][Full Text] [Related]
13. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support).
Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ;
J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333
[TBL] [Abstract][Full Text] [Related]
14. Gastrointestinal bleeding and subsequent risk of thromboembolic events during support with a left ventricular assist device.
Stulak JM; Lee D; Haft JW; Romano MA; Cowger JA; Park SJ; Aaronson KD; Pagani FD
J Heart Lung Transplant; 2014 Jan; 33(1):60-4. PubMed ID: 24021944
[TBL] [Abstract][Full Text] [Related]
15. The use of eptifibatide for suspected pump thrombus or thrombosis in patients with left ventricular assist devices.
Tellor BR; Smith JR; Prasad SM; Joseph SM; Silvestry SC
J Heart Lung Transplant; 2014 Jan; 33(1):94-101. PubMed ID: 24418735
[TBL] [Abstract][Full Text] [Related]
16. Unexpected abrupt increase in left ventricular assist device thrombosis.
Starling RC; Moazami N; Silvestry SC; Ewald G; Rogers JG; Milano CA; Rame JE; Acker MA; Blackstone EH; Ehrlinger J; Thuita L; Mountis MM; Soltesz EG; Lytle BW; Smedira NG
N Engl J Med; 2014 Jan; 370(1):33-40. PubMed ID: 24283197
[TBL] [Abstract][Full Text] [Related]
17. Ambient hemolysis and activation of coagulation is different between HeartMate II and HeartWare left ventricular assist devices.
Birschmann I; Dittrich M; Eller T; Wiegmann B; Reininger AJ; Budde U; Strüber M
J Heart Lung Transplant; 2014 Jan; 33(1):80-7. PubMed ID: 24418734
[TBL] [Abstract][Full Text] [Related]
18. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes.
Kormos RL; Teuteberg JJ; Pagani FD; Russell SD; John R; Miller LW; Massey T; Milano CA; Moazami N; Sundareswaran KS; Farrar DJ;
J Thorac Cardiovasc Surg; 2010 May; 139(5):1316-24. PubMed ID: 20132950
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis, pump thrombus, and neurologic events in continuous-flow left ventricular assist device recipients.
Whitson BA; Eckman P; Kamdar F; Lacey A; Shumway SJ; Liao KK; John R
Ann Thorac Surg; 2014 Jun; 97(6):2097-103. PubMed ID: 24775803
[TBL] [Abstract][Full Text] [Related]
20. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]